Momenta Phama (MNTA) Misses Q1 EPS by 15c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Momenta Phama (MNTA) Misses Q1 EPS by 15c

Momenta Pharmaceuticals (MNTA) PT Raised to $22 at Stifel

May 8, 2018 1:52 PM EDT

Stifel raised its price target on Momenta Pharmaceuticals (NASDAQ: MNTA) to $22.00 (from $21.00) while maintaining a Buy rating.

Analyst Alex Schwartz commented, "Momenta reported 1Q18 earnings that included $4.8 million in revenues, a $47.6 million net loss, and a $346 million cash & equivalents balance. Importantly, Momentas... More

Momenta Pharmaceuticals (MNTA) PT Raised to $23 at Cowen

May 8, 2018 11:59 AM EDT

Cowen raised its price target on Momenta Pharmaceuticals (NASDAQ: MNTA) to $23.00 (from $15.00) while maintaining a Market Perform rating following financials and pipeline update.

Analyst Ken Cacciatore commented, "Given the current cash balances combined with what we believe will be an eventual acceleration in 40mg... More